Cyclacel Pharmaceuticals, Inc. (CYCC)
NASDAQ: CYCC · Real-Time Price · USD
0.505
-0.122 (-19.44%)
At close: Nov 4, 2024, 4:00 PM
0.510
+0.005 (1.01%)
After-hours: Nov 4, 2024, 7:59 PM EST
Cyclacel Pharmaceuticals Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
TTM
| FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Net Income | -17.51 | -22.56 | -21.2 | -18.46 | -8.45 | -7.83 | |
Depreciation & Amortization | 0.02 | 0.03 | 0.03 | 0.04 | 0.02 | 0.02 | |
Loss (Gain) From Sale of Assets | - | - | - | - | - | -0.04 | |
Stock-Based Compensation | 1.11 | 1.47 | 1.51 | 1.16 | 0.43 | 0.47 | |
Other Operating Activities | -0.06 | -0.07 | 0.04 | 0.17 | -0.09 | -0.07 | |
Change in Accounts Payable | 0.31 | 0.3 | 2.58 | 3.03 | 0.03 | -2.21 | |
Change in Other Net Operating Assets | 4.62 | 4.71 | -3.78 | -4.48 | 0.12 | 0.21 | |
Operating Cash Flow | -11.51 | -16.11 | -20.83 | -18.54 | -7.93 | -9.45 | |
Capital Expenditures | - | -0.01 | -0.01 | -0.03 | -0.1 | -0.01 | |
Sale of Property, Plant & Equipment | - | - | - | - | - | 0.04 | |
Investing Cash Flow | - | -0.01 | -0.01 | -0.03 | -0.1 | 0.03 | |
Issuance of Common Stock | 7.26 | 1.05 | 3.2 | 21.94 | 25.99 | 4.05 | |
Preferred Dividends Paid | -0.1 | -0.2 | -0.2 | -0.2 | -0.2 | -0.2 | |
Dividends Paid | -0.1 | -0.2 | -0.2 | -0.2 | -0.2 | -0.2 | |
Other Financing Activities | - | - | - | - | -0.06 | - | |
Financing Cash Flow | 7.16 | 0.85 | 3 | 21.74 | 29.5 | 3.85 | |
Foreign Exchange Rate Adjustments | 0.19 | 0.3 | -0.38 | -0.02 | 0.05 | -0.05 | |
Net Cash Flow | -4.16 | -14.97 | -18.21 | 3.15 | 21.52 | -5.62 | |
Free Cash Flow | -11.51 | -16.12 | -20.83 | -18.57 | -8.03 | -9.46 | |
Free Cash Flow Margin | -14391.25% | -3837.62% | - | - | - | - | |
Free Cash Flow Per Share | -6.38 | -18.94 | -27.76 | -31.20 | -33.15 | -173.83 | |
Cash Income Tax Paid | - | -4.84 | -3.31 | -1.36 | -1.29 | -1.16 | |
Levered Free Cash Flow | -7.66 | -11.76 | -15.34 | -12.21 | -6.16 | -7.46 | |
Unlevered Free Cash Flow | -7.64 | -11.76 | -15.34 | -12.21 | -6.16 | -7.46 | |
Change in Net Working Capital | -3.86 | -2.65 | -0.42 | -0.61 | -0.14 | 1.88 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.